CHILDRENS MERCY HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $21.3M
- Transactions
- 4,613
- Companies
- 40
- Average per transaction
- $4,622
Who reported the payments
| Vertex | $2,326,140 |
| Biofire Diagnostics, LLC | $2,130,069 |
| Jazz Pharmaceuticals Inc. | $1,816,985 |
| Edwards Lifesciences | $1,420,305 |
| Pfizer | $1,313,036 |
| Merck | $1,294,010 |
| Ultragenyx Pharmaceutical Inc. | $1,246,899 |
| Amgen | $796,086 |
| Sanofi Pasteur Inc. | $697,219 |
| Janssen Research & Development, LLC | $656,691 |
| AstraZeneca | $549,727 |
| Gen-probe, Inc. | $474,597 |
| Organon | $471,687 |
| Eli Lilly | $464,166 |
| Albireo Pharma, Inc. | $449,364 |
| Rhythm Pharmaceuticals, Inc. | $327,141 |
| Novartis | $292,528 |
| Dexcom, Inc. | $240,344 |
| Gilead | $230,453 |
| Astellas Pharma Global Development | $221,975 |
| Novo Nordisk AS | $219,556 |
| Acadia Pharmaceuticals Inc | $209,898 |
| AbbVie | $205,076 |
| Travere Therapeutics, Inc. | $188,938 |
| Orthopediatrics Corp. | $180,000 |
| Genentech, Inc. | $178,487 |
| Luminex Corporation | $160,201 |
| Immedica Pharma US, Inc. | $157,505 |
| Abbott | $150,445 |
| Purdue Pharma L.p. | $110,500 |
| Boehringer Ingelheim | $107,778 |
| Biomerieux Inc | $107,489 |
| Hyperfine Operations, Inc. | $105,975 |
| Bayer | $90,735 |
| Sanofi | $85,509 |
| Cepheid | $82,600 |
| BD | $74,609 |
| GE HealthCare | $73,818 |
| Qiagen, LLC | $70,113 |
| Baxter Healthcare | $68,000 |